PolyPid Ltd. (PYPD) Financials
PYPD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 15.4 million | 17.5 million |
2023-09-30 | 20.9 million | 17.4 million |
2023-06-30 | 26.3 million | 17.9 million |
2023-03-31 | 31.7 million | 20.3 million |
PYPD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | ? | ? |
2023-06-30 | ? | ? |
2023-03-31 | ? | ? |
PYPD Net Income
No data available :(
PYPD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 5.6 million | - | 1.4 million |
2023-09-30 | 10.2 million | - | 1.3 million |
2023-06-30 | 15.1 million | - | 1.6 million |
2023-03-31 | 13.4 million | - | 1.9 million |
PYPD Shares Outstanding
PYPD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 4.6 million | 1.2 million | 193000 |
2023-09-30 | - | 3.8 million | 1.2 million | 261000 |
2023-06-30 | - | 4.0 million | 1.7 million | 166000 |
2023-03-31 | - | 3.8 million | 1.6 million | 385000 |
PYPD Cost of Revenue
No data available :(
PYPD
Price: $4.94
52 week price:
Earnings Per Share: -16.99 USD
P/E Ratio: -0.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 407700
Market Capitalization: 22.1 million